Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Null Results in Brief

XRCC2 and XRCC3 Polymorphisms Are Not Associated with Risk of Colorectal Adenoma

Gregory J. Tranah, Edward Giovannucci, Jing Ma, Charles Fuchs, Susan E. Hankinson and David J. Hunter
Gregory J. Tranah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Giovannucci
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Ma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Fuchs
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan E. Hankinson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Hunter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published June 2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Introduction

The XRCC2 and XRCC3 proteins participate in homologous recombination and DNA double-strand break repair to maintain chromosomal stability. Coding-region variants in XRCC2 (Arg188His) and XRCC3 (Thr241Met) have been associated with cancers at several sites (1-3). The XRCC3 241Met homozygous variant has also been associated with increased DNA adduct levels, suggesting a role for this protein in repairing DNA adducts (2).

We assessed the association between XRCC2 R188H, XRCC3 T241M, and two intronic XRCC3 polymorphisms and risk of colorectal adenoma in two case-control studies nested in the Nurses' Health Study (NHS) and the Health Professionals Follow-up Study (HPFS) cohorts. We hypothesize that XRCC2 and XRCC3 polymorphisms modify risk of colorectal adenoma associated with smoking and alcohol intake; both established risk factors for colorectal adenoma (4). In addition, we examine the XRCC2 and XRCC3 polymorphisms and their potential interaction with plasma and dietary folate in relation to risk of colorectal adenoma.

Materials and Methods

Detailed information about the design of the NHS (cases, n = 556; controls, n = 557) and HPFS (cases, n = 376; controls, n = 725) nested case-control studies has been published previously (4). Genotyping of coding region XRCC2 R188H (rs3218536) and XRCC3 T241M (rs861539), and intronic XRCC3 A>G 4541 (rs1799794) and XRCC3 A>G 17893 (rs1799796) single nucleotide polymorphisms was carried out using the TaqMan allelic discrimination system (Applied Biosystems, Foster City, CA). Plasma folate was measured for some of the NHS nested case-control participants (cases, n = 345; controls, n = 333) (5). Odds ratios and 95% confidence intervals were calculated using conditional and unconditional logistic regression and were adjusted for established colorectal cancer risk factors (4). Interactions between genotype and exposure to smoking, dietary folate, plasma folate, and alcohol intake were tested by the likelihood ratio test.

Results

The distribution of the XRCC2 and XRCC3 genotypes conformed to Hardy-Weinberg expectations and these polymorphisms were not in linkage disequilibrium. We observed no association between XRCC2 and XRCC3 genotype and risk of colorectal adenoma in separate and combined analyses of women and men from the NHS and HPFS cohorts, respectively (Table 1). In addition, no difference in risk was found between early (tubular histology and <1 cm in diameter) and advanced (villous or tubulovillous histology and ≥1 cm in diameter) lesions in men and women (data not shown). No statistically significant interactions were observed between genotype and smoking, alcohol intake, dietary folate, or plasma folate (data available from www.channing.harvard.edu/nhs/pub.html#xrcc2004). Cigarette smoking increased risk of colorectal adenoma in our study for both men and women, regardless of XRCC2 or XRCC3 genotype. In addition, alcohol intake increased risk of colorectal adenoma in men for all genotypes. There was no evidence that the effect of XRCC2 or XRCC3 genotype varied by plasma or dietary folate in NHS.

View this table:
  • View inline
  • View popup
Table 1.

Associations between XRCC genotypes and colorectal adenoma risk in the NHS and the HPFS

Discussion

In the present study, we observed no association between XRCC2 and XRCC3 and risk of colorectal adenoma. We had >80% power to detect risk ratios of 1.6 (XRCC2 R188H), 1.7 (XRCC3 T241M), 1.7 (XRCC3 A>G 17893), and 2.4 (XRCC3 A>G 4541) for homozygous carriers of the variant alleles in both groups. XRCC2 and XRCC3 are required for the formation of the protein complex necessary for homologous recombination repair of DNA double-strand breaks, which, if not repaired, can lead to chromosome rearrangement and genomic instability. DNA double-strand breaks can arise during DNA replication and are also induced by some carcinogens. High alcohol consumption has been related to higher risk of colorectal neoplasia through an antifolate effect, which may lead to uracil misincorporation into DNA and result in chromosomal breaks (4). DNA in human colon cells can also be damaged by adduct forming carcinogens derived from tobacco smoke (6). The XRCC2 and XRCC3 polymorphisms analyzed here did not modify the association between smoking, plasma folate, dietary folate, alcohol consumption, and adenoma risk. Our results suggest that cigarette smoking and high alcohol intake increase the risk of colorectal adenoma in men and women regardless of XRCC2 and XRCC3 genotypes.

Acknowledgments

We thank the participants of the Nurses' Health Study and the Health Professionals Follow-up Study for their cooperation and participation. The authors are grateful to Hardeep Ranu for technical assistance.

Footnotes

  • Grant support: Research grants CA70817, CA 87969, and CA 55075 from NIH. G. Tranah is supported by a training grant CA09001-27 from NIH.

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Accepted February 3, 2004.
    • Received January 13, 2004.

References

  1. ↵
    Kuschel B, Auranen A, McBride S, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 2002;11:1399-407.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Matullo G, Guarrera S, Carturan S, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 2001;92:562-67.
    OpenUrlCrossRefPubMed
  3. ↵
    Rafii S, O'Regan P, Xinarianos G, et al. A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer. Hum Mol Genet 2002;11:1433-38.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Giovannucci E, Stampfer MJ, Colditz GA, et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993;85:875-84.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Zhang SM, Willett WC, Selhub J, et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 2003;95:373-80.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Alexandrov K, Rojas M, Kadlubar FF, Lang NP, Bartsch H. Evidence of anti-benzo[a]pyrene diolepoxide-DNA adduct formation in human colon mucosa. Carcinogenesis 1996;17:2081-83.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 13 (6)
June 2004
Volume 13, Issue 6
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
XRCC2 and XRCC3 Polymorphisms Are Not Associated with Risk of Colorectal Adenoma
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
XRCC2 and XRCC3 Polymorphisms Are Not Associated with Risk of Colorectal Adenoma
Gregory J. Tranah, Edward Giovannucci, Jing Ma, Charles Fuchs, Susan E. Hankinson and David J. Hunter
Cancer Epidemiol Biomarkers Prev June 1 2004 (13) (6) 1090-1091;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
XRCC2 and XRCC3 Polymorphisms Are Not Associated with Risk of Colorectal Adenoma
Gregory J. Tranah, Edward Giovannucci, Jing Ma, Charles Fuchs, Susan E. Hankinson and David J. Hunter
Cancer Epidemiol Biomarkers Prev June 1 2004 (13) (6) 1090-1091;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Associations of ACEi and ARB with CRC risk
  • PDE5 Inhibitor Use and Precursors of Colorectal Cancer
  • Association Between Serum Iron Biomarkers and Breast Cancer
Show more Null Results in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement